Brodin T., Fick J., Jonsson M. and Klaminder J. 2013. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science, 339(6121): 814–815. doi:
10.1126/ science.1226850
Calisto V., Domingues M.R.M. and Esteves V.I. 2011. Photodegrad-ation of psychiatric pharmaceut-icals in aquatic environments- Kinetics and photodegradation products. Water Research, 45(18): 6097–6106. doi:
10.1016/j.watres.20 11.09.008
Chen K., Wu M., Chen C., Xu H., Wu X. and Qiu X. 2021. Impacts of chronic exposure to sublethal diazepam on behavioral traits of female and male zebrafish (
Danio rerio). Ecotoxicology and Environmental Safety, 208: 1–9 (111747). doi:
10.1016/j.ecoenv.20 20.111747
Clark D., Pazdernik N. and McGehee M. 2019. Cells and organisms. P: 2–37. In: Clark D.P., Pazdernik N.J. and McGehee M.R. (Eds.). Molecular Biology. Academic Press, UK.
Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., Elkhayat S.I., Bartels B.K., Tien A.K. Tien D.H., Mohnot S., Beeson E., Glasgow E., Amri H., Zukowska Z. and Kalueff A.V. 2009. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behavioural Brain Research, 205(1): 38–44. doi:
10.1016/j.bbr.20 09.06.022
Gerlai R. 2010. Zebrafish anti-predatory responses: A future for translational research? Behavioural Brain Research, 207(2): 223–231. doi:
10.1016/j.bbr.2009.10.008
Giacomini A.C.V.V., Abreu M.S., Giacomini L.V., Siebel A.M., Zimerman F.F., Rambo C.L., Mocelin R., Bonan C.D., Piato A.L., and Barcellos L.J.G. 2016. Fluoxetine and diazepam acutely modulate stress induced-behavior. Behavioural Brain Research, 296: 301–310. doi:
10.1016/j.bbr.2015.09. 027
Goessling W. and Sadler K.C. 2015. Zebrafish: An important tool for liver disease research. Gastroenterology, 149(6): 1361–1377. doi:
10.1053/j.gastro.2015.08.0 34
Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O. and Larsson D.J. 2008. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environmental Science and
Technology, 42(15): 5807–5813. doi:
10.1021/es8005173
Horzmann K.A. and Freeman J.L. 2018. Making waves: New developments in toxicology with the zebrafish. Toxicological Sciences, 163(1): 5–12. doi:
10.109 3/toxsci/kfy044
Lachowicz J., Niedziałek K., Rostkowska E., Szopa A., Świader K., Szponar J. and Serefko A. 2021. Zebrafish as an animal model for testing agents with antidepressant potential. Life, 11(8): 1–19 (792). doi:
10.3390/life 11080792
Levin E.D., Bencan Z. and Cerutti D.T. 2007. Anxiolytic effects of nicotine in zebrafish. Physiology and
Behavior, 90(1): 54–58. doi:
10.1016/j.physbeh.2006.08.026
Mandelli M., Tognoni G. and Garattini S. 1978. Clinical pharmacokinetics of diazepam. Clinical Pharmacokinetics, 3: 72–91. doi: 10.2165/00003088-19780301 0-00005
Manuel R., Gorissen M., Zethof J., Ebbesson L. O., Van De Vis H., Flik G. and Van Den Bos R. 2014. Unpredictable chronic stress decreases inhibitory avoidance learning in Tuebingen long-fin zebrafish: Stronger effects in the resting phase than in the active phase. Journal of Experimental Biology, 217(21): 3919–3928. doi:
10.1242/jeb.109736
Marcon M., Herrmann A.P., Mocelin R., Rambo C.L., Koakoski G., Abreu M.S., Conterato G.M.M., Kist L.W., Bogo M.R., Zanatta L., Barcellos L.J.G. and Piato A.L. 2016. Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to brom-azepam, fluoxetine and nortrip-tyline. Psychopharmacology, 233: 3815–3824. doi: 10.1007/s00213-01 6-4408-5
Merwar G., Gibbons J.R., Hosseini S.A. and Saadabadi A. 2023. Nortriptyline. National Center for Biotechnology Information. Retrieved June 5, 2023, from https://www.ncbi.nlm.nih.gov/books/NBK482214/
Nasereddin L., Alnajjar O., Bashar H., Abuarab S.F., Al-Adwan R., Chellappan D.K. and Barakat M. 2024. Corticosteroid-induced psychiatric disorders: Mechanisms, outcomes, and clinical implications. Diseases, 12(12): 1–18 (300). doi:
10.3390/diseases12120300
Overstreet D.H. and Wegener G. 2013. The flinders sensitive line rat model of depression-25 years and still producing. Pharmacological Reviews, 65(1): 143–155. doi:
10.1124/pr.111.005397
Piato A.L., Capiotti K.M., Tamborski A.R., Oses J.P., Barcellos L.J.G., Bogo M.R., Lara D.R., Vianna M.R. and Bonan C.D. 2011. Unpredictable chronic stress model in zebrafish (
Danio rerio): Behavioral and physiological responses. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(2): 561–567. doi:
10.1016/j.pnpbp.2010.12.0 18
Pomara N., Willoughby L.M., Sidtis J.J., Cooper T.B. and Greenblatt D.J. 2005. Cortisol response to diazepam: Its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder. Psychopharmacology, 178: 1–8. doi: 10.1007/s00213-004-1974-8
Porsolt R.D., Le Pichon M. and Jalfre M. 1977. Depression: A new animal model sensitive to antidepressant treatments. Nature, 266(5604): 730–732. doi: 10.1038/2 66730a0
Ramsay J.M., Feist G.W., Varga Z.M., Westerfield M., Kent M.L. and Schreck C.B. 2006. Whole-body cortisol is an indicator of crowding stress in adult zebrafish,
Danio rerio. Aquaculture, 258(1-4): 565–574. doi:
10.1016/j.aquacul ture.2006.04.020
Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J. and Fava M. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11): 1905–1917. doi: 10.1176/ajp.2006.163.11. 1905
Serafini G., Hayley S., Pompili M., Dwivedi Y., Brahmachari G., Girardi P. and Amore M. 2014. Hippocampal neurogenesis, neurotrophic factors and depression: Possible therapeutic targets? CNS and Neurological Disorders-Drug Targets, 13(10): 1708–1721. doi: 10.2174/187152731 3666141130223723
Spellman T. and Liston C. 2020. Toward circuit mechanisms of pathophysiology in depression. American Journal of Psychiatry, 177(5): 381–390. doi: 10.1176/appi. ajp.2020.20030280
Stetler C. and Miller G.E. 2011. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Medicine, 73(2): 114–126. doi: 10.1097/PSY.0b013e3 1820ad12b
Tovote P., Fadok J.P. and Luthi A. 2015. Neuronal circuits for fear and anxiety. Nature Reviews Neuroscience, 16(6): 317–331. doi: 10.1038/nrn3945
Tran S. and Gerlai R.T. 2016. The novel tank test: Handling stress and the context specific psycho-pharmacology of anxiety. Current Psychopharmacology, 5(2): 169–179. doi: 10.2174/2211556005666160 519144414
Von Bernhardi R., Bernhardi L.E.V. and Eugenin J. 2017. What is neural plasticity? Advances in Experimental Medicine and Biology, 1015: 1–15. doi: 10.1007/ 978-3-319-62817-2_1
Wang D., Yang L., Wang J., Hu G., Liu Z., Yan D., Serikuly N., Alpyshov E.T., Demin K.A., Galstyan D.S., Strekalova T., De Abreu M.S., Amstislavskaya T.G. and Kalueff A.V. 2020. Behavioral and physiological effects of acute and chronic kava exposure in adult zebrafish. Neurotoxicology and Teratology, 79: 1–10 (106881). doi: 10.1016/j. ntt.2020.106881
WHO. 2017. Depression and Other common mental disorders: Global health estimates. World Health Organization, Switzerland. 24P.
Zhao Y., Wang Z., Dai J., Chen L., Huang Y. and Zhan Z. 2012. Beneficial effects of benzo-diazepine diazepam on chronic stress-induced impairment of hippocampal structural
plasticity and depression-like behavior in mice. Behavioural Brain Research, 228(2): 339–350. doi:
10.1016/j.bbr. 2011.12.013
Zhu C., Zhang T., Li Q., Chen X. and Wang K. 2023. Depression and anxiety during the COVID-19 pandemic: Epidemiology, mechanism, and treatment. Neuroscience Bulletin, 39(4): 675– 684. doi:
10.1016/j.bbr.2011.12.013
Zimmermann F., Altenhofen S., Kist L., Leite C., Bogo M., Cognato G. and Bonan C.D. 2016. Unpredictable chronic stress alters adenosine metabolism in zebrafish brain. Molecular Neurobiology, 53: 2518–2528. doi: 10.1007/s12035-015-9270-7
)